| Value | ₹2.93 Cr |
|---|
NSE filing, NSE: TMB. Summary written from the filing by ALFA Finder's alert engine.
Tamilnad Mercantile Bank Ltd: key numbers
- Share price
- ₹784.85
- Market cap
- ₹12,428 Cr
- Revenue (annual)
- ₹5,819 Cr
- Net profit (annual)
- ₹1,338 Cr
- P/E (TTM)
- 7.9×Sector 19.1×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 6.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Tamilnad Mercantile Bank Ltd
All →Tamilnad Mercantile Bank Results Correction
TMB clarified its ₹304.24 crore ECL provision is proactive, not a regulatory shortfall. The ECL framework applies from April 2027 under RBI rules.
Tamilnad Mercantile Bank Business Update
Tamilnad Mercantile Bank won two Oracle Excellence Awards 2026 for Customer and Employee Experience at Oracle AI World, Las Vegas. The recognition highlights the bank's digital excellence with no monetary value attached.
Tamilnad Mercantile Bank Results Update
TMB's press release reports Q2 net profit up 42.09% to ₹451 Crore. Total business rose 27.25%, and gross NPA fell to a 10-year low of 0.61%.
Tamilnad Mercantile Bank Earnings Call Transcript: Key Takeaways
TMB reported record quarterly net profit driven by strong net interest income and significant RAM segment growth.
- Call
- Guides 22% growth
Tamilnad Mercantile Bank Investor Presentation: Key Takeaways
Q2 FY27: total business ₹1,30,237 Cr (+27.25% YoY), record net profit ₹451 Cr (+42.09%), ROE 16.92%, GNPA 0.61%, NNPA 0.14%.
Tamilnad Mercantile Bank Q2 FY27 Results: Net Profit ₹451.1 Cr, Up 42.1% YoY
Tamilnad Mercantile Bank Ltd reported revenue from operations of ₹1,820 Cr (+28.8% YoY) and net profit of ₹451.1 Cr (+42.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹451.1 Cr · +42.1% YoY
Other legal & regulatory announcements
All →Nephrocare Health Services Legal & Regulatory
Nephrocare's Uzbek subsidiary won a court ruling invalidating a ₹14.79 crore tax demand. The tax department must reconsider the audit, and the decision remains appealable.
- Value
- ₹14.79 Cr
Supriya Lifescience Legal & Regulatory
Supriya Lifescience disclosed that its General Manager, Sales & Marketing, was granted bail in an NDPS Act case. The company says the order has no material impact.
Muthoot Finance Legal & Regulatory
Muthoot Finance disclosed a GST Department search and seizure at its Registered Office, conducted October 29-30, 2026. The company states business operations remained unaffected and it is cooperating fully.
Praveg Legal & Regulatory
Praveg received a SEBI penalty order of ₹2 lakh over amalgamation-related non-compliance. The penalty is payable within 45 days.
- Value
- ₹0.02 Cr
Tube Investments of India Legal & Regulatory
Tube Investments received a Punjab Pollution Control Board order imposing ₹39 lakh environmental compensation for partial non-compliance with its Consent to Operate. The company says there is no material impact on its operations or finances.
- Value
- ₹0.39 Cr
Mitsu Chem Plast Legal & Regulatory
Mitsu Chem Plast clarified a late disclosure of its auditor's conversion into an LLP. No auditor change occurred, and the company acknowledged the lapse.